Skip to content
March 15, 2024

Equity.Guru

Investment information for the new generation

Search

GMP

XPhyto Therapeutics (XPHY.C) announced today that its Good Manufacturing Practice (GMP) mescaline synthesis program is on schedule with the completion of initial production batches.   “With both its North…
Algernon Pharmaceuticals (AGN.C) awarded the contract for the synthesis and manufacture of the psychoactive ingredient and finished product for its AP-188 DMT project to Canadian-based Dalton Pharma Services today,…
Isracann Biosciences (IPOT.C) made the decision to go ahead and import their Canadian cannabis into Israel today, according to a press release. It’s an entirely logical choice as the…
Namaste Technologies (N.V) is looking to buy out the rest of CannMart labs from their owners MKD Holdings and JLLS Holdings in an all-share deal for approximately $4 million….
Five days ago, the embattled Israeli government announced “a road map to legalize cannabis within one year” creating a regulated market for adult-use marijuana….
October 14, 2020 Isracann announced that “the government of Israel has officially enacted the legislation for the export of medical cannabis, clearing the way for sales abroad that the…
Medipharms Labs (LABS.T) and DanCann Pharma A/S entered into a new white-labelling supply agreement today. The company will draw raw material from both GMP approved facilities, MediPharm labs and…
IM Cannabis (IMCC.C) announced its first shipment from its EU-GMP supply partner into Germany yesterday, as well as their three new distribution agreements penned by Adjupharm GmbH, it’s German…
The beginning of recreational weed in Israel is likely to boost IPOT’s bottom line….